Anti-THSD7A antibodies are used in the immunodetection of the protein thrombospondin type 1 domain containing 7A. In humans, the canonical protein has a reported length of 1657 amino acid residues and a mass of 185.4 kDa. Its subcellular localization is in the cell membrane. Among its functions, THSD7A is involved with cytoskeleton organization and angiogenesis. Post-translational modifications have been described, including N-glycosylation and protein cleavage. Synonyms for this target antigen include thrombospondin type-1 domain-containing protein 7A and thrombospondin, type I, domain containing 7A.